Head and neck paraganglioma in Pacak-Zhuang syndrome
Authors:
- Jared S RosenblumJRJared S Rosenblum
- Yasemin ColeYasemin Cole
- Danielle DangDDDanielle Dang
- Pashayar P LookianPLPashayar P Lookian
- Hussam AlkaissiHAHussam Alkaissi
- Mayank PatelMPMayank Patel
- Anthony J CappadonaACAnthony J Cappadona
- Abhishek JhaAJAbhishek Jha
- Nancy EdwardsNENancy Edwards
- Danielle R DonahueDDDanielle R Donahue
- Jeeva MunasingheJMJeeva Munasinghe
- Herui WangHWHerui Wang
- 3 January 2025
- journal article
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 9 (1)
Abstract
Background: Head and neck paragangliomas (HNPGLs) are typically slow-growing, hormonally inactive tumors of parasympathetic paraganglia. Inactivation of prolyl-hydroxylase domain-containing 2 protein causing indirect gain-of-function of hypoxia-inducible factor-2α (HIF-2α), encoded by EPAS1, was recently shown to cause carotid body hyperplasia. We previously described a syndrome with multiple sympathetic paragangliomas caused by direct gain-of-function variants in EPAS1 (Pacak-Zhuang syndrome, PZS) and developed a corresponding mouse model. Methods: We evaluated a cohort of patients with PZS (n = 9) for HNPGL by positron emission tomography, magnetic resonance imaging, and computed tomography and measured carotid body size compared to literature reference values. Resected tumors were evaluated by histologic sectioning and staining. We evaluated the corresponding mouse model at multiple developmental stages (P8 and adult) for lesions of the head and neck by high resolution ex vivo imaging and performed immunohistochemical staining on histologic sections of the identified lesions. Results: Three patients had imaging consistent with HNPGL, one of which warranted resection and was confirmed on histology. Three additional patients had carotid body enlargement (Z-score > 2.0), and 3 had carotid artery malformations. We found that 9 of 10 adult variant mice had carotid body tumors and 6 of 8 had a paraganglioma on the cranio-caval vein, the murine homologue of the superior vena cava; these were also found in 4 of 5 variant mice at post-natal day 8. These tumors and the one resected from a patient were positive for tyrosine hydroxylase, synaptophysin, and chromogranin A. Brown fat in a resected patient tumor carried the EPAS1 pathogenic variant. Conclusions: These findings (1) suggest HNPGL as a feature of PZS and (2) show that these pathogenic variants are sufficient to cause the development of these tumors, which we believe represents a continuous spectrum of disease starting from hyperplasia.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Cancer Institute
This publication has 39 references indexed in Scilit:
- Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosisActa Neuropathologica, 2023
- Overview of the 2022 WHO Classification of Paragangliomas and PheochromocytomasEndocrine Pathology, 2022
- The transcriptional portraits of the neural crest at the individual cell levelSeminars in Cell & Developmental Biology, 2022
- Hypoxia inducible factor‐2α importance for migration, proliferation, and self‐renewal of trunk neural crest cellsDevelopmental Dynamics, 2020
- Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation SyndromeJAMA Ophthalmology, 2020
- Genomic Landscape of Pheochromocytoma and ParagangliomaTrends in Cancer, 2018
- Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine TumoursEndocrine Pathology, 2017
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- The Role of Hypoxia in Development of the Mammalian EmbryoDevelopmental Cell, 2009
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008